한글목차

부갑상선기능저하증 시장(2024-2028)

부갑상선기능저하증 시장은 2023년부터 2028년까지 4억 7,490만 달러 규모로 확대될 것으로 예상되며, 예측 기간 동안 7.6%의 CAGR로 성장할 것으로 예상됩니다. 부갑상선기능저하증 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 갑상선 치료에 대한 인식 제고 프로그램 증가, 부갑상선기능저하증에 대한 신약 승인, 신약 개발 활동의 확대에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년간 부갑상선기능저하증 시장 성장을 견인할 주요 요인 중 하나로 벤더들의 무기적 성장 전략 활용 확대를 꼽고 있습니다. 또한 부갑상선기능저하증에 대한 새로운 치료법의 출현과 부갑상선기능저하증 치료 임상시험의 증가는 시장의 큰 수요를 창출할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio에 의한 분석

• 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제5장 시장 규모 실적

• 부갑상선기능저하증 세계 시장(2018-2022년)
• 제품별 분석(2018-2022년)
• 유통 채널별 분석(2018-2022년)
• 지역별 분석(2018-2022년)
• 국가별 분석(2018-2022년)

제6장 정성 분석

• 세계의 부갑상선기능저하증 시장에 대한 인공지능(AI)의 영향

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 제품별

• 시장 세분화
• 비교 : 제품별
• 부갑상선호르몬 : 시장 규모와 예측(2023-2028년)
• 비타민 D 유사체 : 시장 규모와 예측(2023-2028년)
• 칼슘 보충제 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 제품별 시장 기회

제9장 시장 세분화 : 유통 채널별

• 시장 세분화
• 비교 : 유통 채널별
• 병원 약국 : 시장 규모와 예측(2023-2028년)
• 소매 약국 : 시장 규모와 예측(2023-2028년)
• 온라인 약국 : 시장 규모와 예측(2023-2028년)
• 유통 채널별 시장 기회

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 프랑스 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 인도 : 시장 규모와 예측(2023-2028년)
• 이탈리아 : 시장 규모와 예측(2023-2028년)
• 브라질 : 시장 규모와 예측(2023-2028년)
• 지역별 시장 기회

제12장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제13장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AdvaCare Pharma
• Alkem Laboratories Ltd.
• Ascendis Pharma AS
• Cipla Inc.
• COSCIENS BIOPHARMA
• Extend Biosciences Inc
• F. Hoffmann La Roche Ltd.
• La Renon Healthcare Pvt. Ltd.
• LLOYD Inc.
• Lupin Ltd.
• Merck and Co. Inc.
• Pfizer Inc.
• Sigmapharm Laboratories LLC
• Sun Pharmaceutical Industries Ltd.
• Wockhardt Ltd.

제15장 부록

영문목차

Hypoparathyroidism Market 2024-2028

The hypoparathyroidism market is forecasted to grow by USD 474.9 million during 2023-2028, accelerating at a CAGR of 7.6% during the forecast period. The report on the hypoparathyroidism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased awareness programs for thyroid treatment, approval of new medications for hypoparathyroidism, and expansion in drug discovery efforts.

Technavio's hypoparathyroidism market is segmented as below:

By Product

• Parathyroid hormone
• Vitamin D analogue
• Calcium supplement
• Others

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing use of inorganic growth strategies by vendors as one of the prime reasons driving the hypoparathyroidism market growth during the next few years. Also, emergence of new therapies for hypoparathyroidism and rising number of clinical trials for hypoparathyroidism treatment will lead to sizable demand in the market.

The report on the hypoparathyroidism market covers the following areas:

• Hypoparathyroidism Market sizing
• Hypoparathyroidism Market forecast
• Hypoparathyroidism Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hypoparathyroidism market vendors that include AdvaCare Pharma, Alkem Laboratories Ltd., Ascendis Pharma AS, AstraZeneca Plc, Cipla Inc., COSCIENS BIOPHARMA, Extend Biosciences Inc, F. Hoffmann La Roche Ltd., La Renon Healthcare Pvt. Ltd., LLOYD Inc., Lupin Ltd., Merck and Co. Inc., Pfizer Inc., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., VISEN Pharmaceuticals Co Ltd, and Wockhardt Ltd.. Also, the hypoparathyroidism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Hypoparathyroidism Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hypoparathyroidism Market 2018 - 2022 ($ million)
• 5.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 5.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 Impact of Artificial Intelligence (AI) in the global hypoparathyroidism market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Product

• 8.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 8.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 8.3 Parathyroid hormone - Market size and forecast 2023-2028
  • Chart on Parathyroid hormone - Market size and forecast 2023-2028 ($ million)
  • Data Table on Parathyroid hormone - Market size and forecast 2023-2028 ($ million)
  • Chart on Parathyroid hormone - Year-over-year growth 2023-2028 (%)
  • Data Table on Parathyroid hormone - Year-over-year growth 2023-2028 (%)
• 8.4 Vitamin D analogue - Market size and forecast 2023-2028
  • Chart on Vitamin D analogue - Market size and forecast 2023-2028 ($ million)
  • Data Table on Vitamin D analogue - Market size and forecast 2023-2028 ($ million)
  • Chart on Vitamin D analogue - Year-over-year growth 2023-2028 (%)
  • Data Table on Vitamin D analogue - Year-over-year growth 2023-2028 (%)
• 8.5 Calcium supplement - Market size and forecast 2023-2028
  • Chart on Calcium supplement - Market size and forecast 2023-2028 ($ million)
  • Data Table on Calcium supplement - Market size and forecast 2023-2028 ($ million)
  • Chart on Calcium supplement - Year-over-year growth 2023-2028 (%)
  • Data Table on Calcium supplement - Year-over-year growth 2023-2028 (%)
• 8.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 8.7 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Distribution Channel

• 9.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 9.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• 9.4 Retail pharmacy - Market size and forecast 2023-2028
  • Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• 9.5 Online pharmacy - Market size and forecast 2023-2028
  • Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• 9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.12 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.13 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 11.14 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.15 Italy - Market size and forecast 2023-2028
  • Chart on Italy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Italy - Market size and forecast 2023-2028 ($ million)
  • Chart on Italy - Year-over-year growth 2023-2028 (%)
  • Data Table on Italy - Year-over-year growth 2023-2028 (%)
• 11.16 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 AdvaCare Pharma
  • AdvaCare Pharma - Overview
  • AdvaCare Pharma - Product / Service
  • AdvaCare Pharma - Key offerings
  • SWOT
• 14.5 Alkem Laboratories Ltd.
  • Alkem Laboratories Ltd. - Overview
  • Alkem Laboratories Ltd. - Business segments
  • Alkem Laboratories Ltd. - Key offerings
  • Alkem Laboratories Ltd. - Segment focus
  • SWOT
• 14.6 Ascendis Pharma AS
  • Ascendis Pharma AS - Overview
  • Ascendis Pharma AS - Product / Service
  • Ascendis Pharma AS - Key offerings
  • SWOT
• 14.7 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
• 14.8 COSCIENS BIOPHARMA
  • COSCIENS BIOPHARMA - Overview
  • COSCIENS BIOPHARMA - Product / Service
  • COSCIENS BIOPHARMA - Key offerings
  • SWOT
• 14.9 Extend Biosciences Inc
  • Extend Biosciences Inc - Overview
  • Extend Biosciences Inc - Product / Service
  • Extend Biosciences Inc - Key offerings
  • SWOT
• 14.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 14.11 La Renon Healthcare Pvt. Ltd.
  • La Renon Healthcare Pvt. Ltd. - Overview
  • La Renon Healthcare Pvt. Ltd. - Product / Service
  • La Renon Healthcare Pvt. Ltd. - Key offerings
  • SWOT
• 14.12 LLOYD Inc.
  • LLOYD Inc. - Overview
  • LLOYD Inc. - Product / Service
  • LLOYD Inc. - Key offerings
  • SWOT
• 14.13 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
• 14.14 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 14.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.16 Sigmapharm Laboratories LLC
  • Sigmapharm Laboratories LLC - Overview
  • Sigmapharm Laboratories LLC - Product / Service
  • Sigmapharm Laboratories LLC - Key offerings
  • SWOT
• 14.17 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 14.18 Wockhardt Ltd.
  • Wockhardt Ltd. - Overview
  • Wockhardt Ltd. - Business segments
  • Wockhardt Ltd. - Key offerings
  • Wockhardt Ltd. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations